BCR-ABL fusion protein lacks Myr-bound cap region and thus stays in a constitutively active state, with enhanced stability and binding to F-actin, resulting in hyper-proliferation of the CML cells [11]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.